Search

everythinglearnresearchcommunity

for

Search:↓

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Hirsutism in young girls can have causes other than PCOS, so diagnoses should be reassessed if treatments don't work.

Spironolactone treatment increases the amount of testosterone available in the body.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Older people in Kerala often have skin conditions, with dry skin being the most common, and certain skin issues are linked to high cholesterol and diabetes.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Psoriasis is the most common cause of erythroderma, and proper medical follow-up is crucial.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

The dog recovered from hypothyroidism and regrew its hair after two months of treatment.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Tofacitinib is a promising treatment for children with rheumatic diseases.